Insiders Of Avid Bioservices Reap Rewards After Their Investment Jumps Another US$385k
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
Sector Update: Health Care
Avid Bioservices Shares Jump as RBC Boosts Price Target After Bookings Beat
Avid Bioservices Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Adjusted EPS Results. Also, RBC Capital Maintained an Outperform Rating on the Stock and Raised Its Price Target From $8 to $12.
Avid Bioservices Up Over 20%, on Pace for Largest Percent Increase Since March 2023 -- Data Talk
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating, Announces Target Price $16
RBC Capital Maintains Avid Bioservices(CDMO.US) With Buy Rating, Raises Target Price to $12
Express News | William Blair Reiterates Market Perform on Avid Bioservices
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Express News | Avid Bioservices Inc : RBC Raises Target Price to $12 From $8
Avid Bioservices, Inc. (CDMO) Q1 2025 Earnings Call Transcript Summary
Avid Bioservices Reports Growth and Strong Pipeline
Avid Bioservices | 10-Q: Q1 2025 Earnings Report
Avid Bioservices GAAP EPS of -$0.09 Misses by $0.03, Revenue of $40.17M Misses by $0.65M
Avid Bioservices: Fiscal Q1 Earnings Snapshot
Avid Bioservices 1Q Loss/Shr 9c >CDMO
Express News | Avid Bioservices Outlook FY Revenue USD 160-168 Million
Express News | Avid Bioservices Q1 Net Income USD -5.5 Million